TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $528.0K2010: $2.10M2011: $509.0K2012: $303.0K2013: $4.22M2014: $1.93M2015: $4.88M2016: $2.75M2017: $1.79M2018: $813.0K2019: $731.0K2020: $1.55M2021: $1.25M2022: $1.83M2023: $1.82M2024: $1.92M2025: $2.71M$2.71M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.71M+41.4%
2024$1.92M+5.6%
2023$1.82M-0.5%
2022$1.83M+46.4%
2021$1.25M-19.5%
2020$1.55M+112.3%
2019$731.0K-10.1%
2018$813.0K-54.5%
2017$1.79M-35.0%
2016$2.75M-43.6%
2015$4.88M+152.8%
2014$1.93M-54.3%
2013$4.22M+1292.4%
2012$303.0K-40.5%
2011$509.0K-75.8%
2010$2.10M+297.7%
2009$528.0K—